Skip to content

ADXN

Addex Therapeutics Ltd.

NASDAQ · Healthcare · Biotechnology · CH

$3.40
+1.19%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-48.2%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Sep 4, 2026Teyssedou Lenaic Nathanael · officer: PRINCIPAL ACCOUNTING OFFICERA-Award100,485$0.03
Sep 4, 2026Kalinichev Mikhail · officer: HEAD OF TRANSLATIONAL SCIENCEA-Award306,765$0.00
Sep 4, 2026Kalinichev Mikhail · officer: HEAD OF TRANSLATIONAL SCIENCEA-Award200,000$0.03
Sep 4, 2026Nunn Jason Raleigh · directorA-Award219,561$0.00
Sep 4, 2026Nunn Jason Raleigh · directorA-Award50,000$0.03
Sep 4, 2026Mills Roger · director, officer: CHIEF MEDICAL OFFICERA-Award392,837$0.00
Sep 4, 2026Mills Roger · director, officer: CHIEF MEDICAL OFFICERA-Award50,000$0.03
Sep 4, 2026Manke Isaac · directorA-Award219,561$0.00
Sep 4, 2026Manke Isaac · directorA-Award50,000$0.03
Sep 4, 2026Lawton Vincent Michael · directorA-Award2,507,487$0.00
Sep 4, 2026Lawton Vincent Michael · directorA-Award501,598$0.03
Sep 4, 2026Hill Raymond George · directorA-Award1,365,532$0.00
Sep 4, 2026Hill Raymond George · directorA-Award273,107$0.03
Sep 4, 2026Dyer Timothy Mark · director, officer: CHIEF EXECUTIVE OFFICERA-Award16,413,787$0.00
Sep 4, 2026Dyer Timothy Mark · director, officer: CHIEF EXECUTIVE OFFICERA-Award3,369,796$0.03

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 4, 2026